# Manus Announces Completion of $500 Million Financing

- Category: Flash (快讯)
- Published: 2026-10-08T11:56:00.000Z
- Source date: 2026-10-08
- HTML: https://www.88z.ai/en/news/flash-20261008-9d262e3a2a0a2515
- Markdown: https://www.88z.ai/en/news/flash-20261008-9d262e3a2a0a2515.md
- Other language: https://www.88z.ai/news/flash-20261008-9d262e3a2a0a2515.md

Butterfly Effect, the parent company of Manus, has completed over $500 million in financing, led by Boyu Capital and IDG Capital, with participation from existing shareholders including Tencent. This marks its first funding disclosure since resuming independent operations. Meanwhile, Manus released version 2.0, introducing its self-developed Cascade framework, cloud computers, automated workflows, and the personal intelligent assistant Cue.

## At a glance

- Butterfly Effect completes over $500M financing led by Boyu and IDG, first disclosure since independent operation resumed
- Manus 2.0 launched with self-developed Cascade framework, cloud computers, and intelligent assistant Cue

## The update

Butterfly Effect, the parent company of Manus, recently announced the completion of over five hundred million dollars in financing. This round was co-led by Boyu Capital and IDG Capital, with continued support from existing shareholders such as Tencent, Sequoia China, and ZhenFund. Notably, this is the first time the company has publicly disclosed its funding progress since resuming independent operations. On the product front, Manus officially released version 2.0. This update brings several core technological upgrades, including the self-developed Cascade framework, cloud computer functionality, automated workflow systems, and the new personal intelligent assistant Cue. The addition of these features aims to further enhance the platform's intelligence level and user work efficiency.

## Sources

- [APPSO](https://mp.weixin.qq.com/s/nAbY1xNU6ofoNTtIBPag_A) (2026-10-08)

This article is an AI-assisted synthesis by 88Z AI based on the public sources below. Product claims and availability are attributed to their publishers. It does not represent independent testing or first-hand reporting.